Inhibition of Glutamine Uptake Resensitizes Paclitaxel Resistance in SKOV3-TR Ovarian Cancer Cell via mTORC1/S6K Signaling Pathway.

MLA

Kim, Gyeongmi, et al. “Inhibition of Glutamine Uptake Resensitizes Paclitaxel Resistance in SKOV3-TR Ovarian Cancer Cell via MTORC1/S6K Signaling Pathway.” International Journal of Molecular Sciences, vol. 23, no. 15, Aug. 2022, p. 8761. EBSCOhost, https://doi.org/10.3390/ijms23158761.

APA

Kim, G., Jang, S.-K., Kim, Y. J., Jin, H.-O., Bae, S., Hong, J., Park, I.-C., & Lee, J. H. (2022). Inhibition of Glutamine Uptake Resensitizes Paclitaxel Resistance in SKOV3-TR Ovarian Cancer Cell via mTORC1/S6K Signaling Pathway. International Journal of Molecular Sciences, 23(15), 8761. https://doi.org/10.3390/ijms23158761

Chicago

Kim, Gyeongmi, Se-Kyeong Jang, Yu Jin Kim, Hyeon-Ok Jin, Seunghee Bae, Jungil Hong, In-Chul Park, and Jae Ho Lee. 2022. “Inhibition of Glutamine Uptake Resensitizes Paclitaxel Resistance in SKOV3-TR Ovarian Cancer Cell via MTORC1/S6K Signaling Pathway.” International Journal of Molecular Sciences 23 (15): 8761. doi:10.3390/ijms23158761.